Allmed Solutions Ltd.

Allmed Solutions Ltd.

TTASE:ALMD
28.70
ILA
-0.40
(-1.37%)
3.19BMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
0.47
0.27
0.18
0.16
0.13
0.13
0.14
0.12
0.07
- -
- -
- -
- -
- -
Basic EPS, GAAP
-5.05
-1.34
-0.73
-0.53
-0.39
-0.28
0.27
-0.11
0.03
-0.14
0.01
-0.09
-0.15
- -
Free Cash Flow per Basic Share
-1.39
-1.05
-0.56
-0.39
-0.32
-0.22
-0.15
-0.11
-0.07
-0.12
0.06
-0.08
-0.13
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
2.75
1.49
1.08
0.72
0.54
0.41
0.71
0.61
0.62
0.48
0.49
0.41
0.26
0.2
Tangible Book Value per Share
-0.07
0.27
0.5
0.3
0.25
0.17
0.57
0.47
0.62
0.48
0.49
0.41
0.26
0.2
Basic Weighted Avg Shares
10
18
29
45
58
73
80
80
81
88
108
99
96
99
Sales/Revenue/Turnover
5
5
5
7
8
9
11
10
6
- -
- -
- -
- -
- -
Operating Margin (%)
-814.17
-463.57
-356.57
-307.81
-296.53
-247.1
198.11
-100.82
-165.55
- -
- -
- -
- -
- -
Depreciation Expense
5
2
2
2
2
2
3
2
1
1
- -
1
1
- -
Net Income, GAAP
-50
-25
-21
-24
-23
-20
22
-9
3
-12
1
-9
-14
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
-1,063.71
-501.3
-404.25
-325.27
-294.42
-217.43
197.25
-89.08
50.64
- -
- -
- -
- -
- -
Working Capital
4
11
26
16
18
16
43
36
14
22
55
41
27
23
LT Debt
- -
- -
- -
- -
- -
- -
2
1
- -
- -
1
- -
1
- -
Total Equity
30
32
45
38
39
33
57
49
52
54
56
42
28
24
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
47.75
- -
12.04
- -
-6
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
49.37
- -
5.81
- -
2.69
- -
- -
- -
Return on Common Equity (%)
-102.56
-79.01
-54.17
-57.41
-59.18
-56.69
48.81
-16.29
5.65
-23.82
2.71
-18.88
-43.76
- -

Capital Structure

ILS

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
1
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
96
96
101
Market Capitalization
30
31
32

Working Capital

ILS

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
Total Current Assets
37
30
25
Cash, Cash Equivalents & STI
36
29
24
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
2
3
2
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

ILS

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-1.46%
-8.8%
-33.2%
Free Cash Flow
-32.68%
-55.67%
48.9%
Net Income, GAAP
-178.09%
-286.11%
61.38%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

ILS

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
- -
2025
- -
- -
- -
2026
- -
- -
- -

Semi-annual Earnings Per Share

ILS

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
-0.09
2025
- -
- -
-0.15
2026
- -
- -
- -

Semi-annual Dividends Per Share

ILS

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
- -
2025
- -
- -
- -
2026
- -
- -
- -

Company Description

CEO
Oz Moshe Shapira
Full Time Employees
23
Sector
Health technology
Industry
Pharmaceuticals: other
Address
2 Ha'Eshel Street Or Akiva HA Israel 3063908
IPO Date
Feb 1, 2007
Business
Allmed Solutions Ltd (ALMD.TA) provides comprehensive medical staffing and healthcare workforce solutions, including temporary and permanent placement of nurses, physicians, paramedics, and allied health professionals; home care services; medical equipment rental; and telehealth platforms across Israel. The company operates primarily in the healthcare staffing and medical services sector, targeting hospitals, clinics, nursing homes, and private patients throughout Israel, with headquarters in Petah Tikva and founded in 2003. Its services encompass specialized divisions such as ICU and ER staffing, rehabilitation support, and pharmaceutical distribution through subsidiaries. In recent developments, Allmed expanded its home care offerings with new digital monitoring tools launched in 2024; formed a strategic alliance with major Israeli hospital networks for exclusive staffing contracts in early 2025; and completed a funding round to support geographic expansion into additional regions. The company continues to focus on technology integration for workforce management and patient care optimization.